Clinical Trial

Aveir DR Real-World Evidence Post-Approval Study

Name: Aveir DR Real-World Evidence Post-Approval Study — clinical trial record (NCT05935007)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2023-07-05; most recent amendment 2026-05-18.

Status change: Not Yet Recruiting → Recruiting 2024-02-01

Trial Details

NCT Number	NCT05935007
Lead Sponsor	Abbott Medical Devices
Conditions	Cardiac Pacemaker, Arrythmia, Bradycardia
Enrollment	1,805 participants
Start Date	2023-10-31
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-20